Ventrix Overview

  • Founded
  • 2009
  • Status
  • Private
  • Employees
  • 4
  • Latest Deal Type
  • Grant
  • Latest Deal Amount
  • $1.03M
Latest Deal Amount
  • Investors
  • 2

Ventrix General Information


Provider of a biomaterial scaffold designed to improve cardiac function. The company's scaffold uses novel and innovative biomaterials to harness endogenous repair and is designed specifically for repair of damaged myocardium, enabling patients to get tissue engineering products for cardiovascular disease.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Primary Industry
Surgical Devices
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
  • 3030 Bunker Hill Street
  • Suite 117D
  • San Diego, CA 92109
  • United States
+1 (858) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Ventrix Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Grant 01-Jan-2016 $1.03M 00.000 Completed Generating Revenue
4. Grant 01-Jan-2013 00.000 00.000 Completed Product Development
3. Angel (individual) 31-May-2012 00.000 00.000 000.00 Completed Generating Revenue
2. Grant 01-Jan-2011 $497K Completed Product Development
1. Grant 01-Jul-2010 $180K Completed Product Development
To view Ventrix’s complete valuation and funding history, request access »

Ventrix Cap Table

Stock # of Shares
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.00
To view Ventrix’s complete cap table history, request access »

Ventrix Executive Team (3)

Name Title Board Seat Contact Info
Adam Kinsey Ph.D Co-Founder & Chief Executive Officer
Karen Christman Ph.D Scientific Co-Founder
Paul Chamberlin MD Chief Medical Officer
To view Ventrix’s complete executive team members history, request access »

Ventrix Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ventrix Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
National Institutes of Health Government 000 0000 000000 0
National Science Foundation Government 000 0000 000000 0
To view Ventrix’s complete investors history, request access »